Details for New Drug Application (NDA): 017982
✉ Email this page to a colleague
The generic ingredient in AMIPAQUE is metrizamide. There is one drug master file entry for this compound. Additional details are available on the metrizamide profile page.
Summary for 017982
Tradename: | AMIPAQUE |
Applicant: | Ge Healthcare |
Ingredient: | metrizamide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017982
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3.75GM/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 6.75GM/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2.5GM/VIAL | ||||
Approval Date: | Sep 12, 1983 | TE: | RLD: | No |
Expired US Patents for NDA 017982
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-001 | Approved Prior to Jan 1, 1982 | 3,701,771 | ⤷ Subscribe |
Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-002 | Approved Prior to Jan 1, 1982 | 3,701,771 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription